N-(2-Fluorophenyl)-6-(trifluoromethyl)pyridine-3-carboxamide

Catalog No. :
ACGJCC502
CAS No. :
1092346-30-9
Molecular Formula :
C13H8F4N2O
Molecular Weight :
284.21

IUPAC Name:N-(2-fluorophenyl)-6-(trifluoromethyl)nicotinamide

N-(2-Fluorophenyl)-6-(trifluoromethyl)pyridine-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-Fluorophenyl)-6-(trifluoromethyl)pyridine-3-carboxamide
IUPAC NameN-(2-fluorophenyl)-6-(trifluoromethyl)nicotinamide
MDL No.MFCD11501845
Molecular FormulaC13H8F4N2O
Molecular Weight284.21
SMILESO=C(C1=CC=C(C(F)(F)F)N=C1)NC2=CC=CC=C2F
InChI KeyYDHIPSOGNOKVIT-UHFFFAOYSA-N
SynonymN-(2-fluorophenyl)-6-(trifluoromethyl)pyridine-3-carboxamide;3-Pyridinecarboxamide, N-(2-fluorophenyl)-6-(trifluoromethyl)-;N-(2-Fluorophenyl)-6-(trifluoromethyl)-3-pyridinecarboxamide
CAS No.1092346-30-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGJCC502 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPRQH198 route compound structure diagram
    ACPRQH19851085-49-5 In Stock
  2. Plus
  3. ACJWNQ347 route compound structure diagram
    ACJWNQ347231291-22-8 In Stock
  4. Then
  5. ACGJCC502 route product structure diagram
    ACGJCC5021092346-30-9
Inquiry

2. ACGJCC502 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPRQH198 route compound structure diagram
    ACPRQH19851085-49-5 In Stock
  2. Plus
  3. ACOEKB038 route compound structure diagram
    ACOEKB038358780-13-9 In Stock
  4. Then
  5. ACGJCC502 route product structure diagram
    ACGJCC5021092346-30-9
Inquiry

Comments (0)